Provided by Tiger Trade Technology Pte. Ltd.

Regeneron Pharmaceuticals

656.01
+4.100.63%
Post-market: 656.010.00000.00%19:34 EDT
Volume:708.39K
Turnover:467.40M
Market Cap:69.35B
PE:15.98
High:667.50
Open:658.29
Low:654.05
Close:651.91
52wk High:821.11
52wk Low:541.00
Shares:105.72M
Float Shares:103.30M
Volume Ratio:0.93
T/O Rate:0.69%
Dividend:3.59
Dividend Rate:0.55%
EPS(TTM):41.06
EPS(LYR):41.48
ROE:14.55%
ROA:6.13%
PB:2.21
PE(LYR):15.82

Loading ...

Jul 06, 2026

Major Issues Report

Form 8-K - Current report
Jul 02, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 18, 2026

Major Issues Report

Form 8-K - Current report
Apr 30, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Apr 29, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 29, 2026

Major Issues Report

Form 8-K - Current report
Apr 08, 2026

Major Issues Report

Form 8-K - Current report
Feb 19, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 09, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 09, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 04, 2026

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Jan 30, 2026

Major Issues Report

Form 8-K - Current report
Jan 12, 2026

Major Issues Report

Form 8-K - Current report
Jan 07, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 20, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 07, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 29, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 28, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 28, 2025

Major Issues Report

Form 8-K - Current report
Oct 06, 2025

Major Issues Report

Form 8-K - Current report